NA
EHC icon

Navellier & Associates’s Encompass Health EHC Stock Holding History

Navellier & Associates’s Portfolio EHC Stock Details EHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,596
Closed -$203K – 348
2025
Q3 		$203K Buy
+1,596
New +$190K 0.02% 347

Other funds holding EHC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Navellier & Associates's EHC Position: Q4 2025 in Review

Navellier & Associates sold out of Encompass Health (EHC) in Q4 2025, closing a stake of 1,596 shares — an estimated $203K sold.

Navellier & Associates first reported a position in EHC in Q3 2025 and held it in 1 quarter. The position peaked at $203K in Q3 2025. 594 funds tracked by Wall St. Rank hold EHC as of Q4 2025.

  • Navellier & Associates reported no remaining Encompass Health position as of Q4 2025 after selling out during the quarter.
  • Navellier & Associates sold 1,596 Encompass Health shares in Q4 2025, an estimated $203K.
  • Navellier & Associates first reported a position in Encompass Health in Q3 2025 and held it in 1 quarter.
  • Navellier & Associates's Encompass Health position peaked at $203K in Q3 2025.
  • 594 funds tracked by Wall St. Rank held Encompass Health as of Q4 2025.

Based on Navellier & Associates's 13F filing for Q4 2025, filed 3 Feb 2026.